217 related articles for article (PubMed ID: 23827199)
1. Absence of radiographic progression at two years in a cohort of patients with non-radiographic axial spondyloarthritis treated with TNF-α blockers.
Almirall M; López-Velandia JG; Maymó J
Reumatol Clin; 2014; 10(2):134-5. PubMed ID: 23827199
[No Abstract] [Full Text] [Related]
2. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study.
Durnez A; Paternotte S; Fechtenbaum J; Landewé RB; Dougados M; Roux C; Briot K
J Rheumatol; 2013 Oct; 40(10):1712-8. PubMed ID: 23950191
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
Rudwaleit M; Sieper J
Dtsch Med Wochenschr; 2005 Aug; 130(33):1882-6. PubMed ID: 16118732
[No Abstract] [Full Text] [Related]
4. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Callhoff J; Sieper J; Weiß A; Zink A; Listing J
Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
[TBL] [Abstract][Full Text] [Related]
5. The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis.
Kang KY; Ju JH; Park SH; Kim HY
Rheumatology (Oxford); 2013 Apr; 52(4):718-26. PubMed ID: 23275389
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
7. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
Eder L; Thavaneswaran A; Chandran V; Gladman DD
Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
[TBL] [Abstract][Full Text] [Related]
9. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.
Gremese E; Bernardi S; Bonazza S; Nowik M; Peluso G; Massara A; Tolusso B; Messuti L; Miceli MC; Zoli A; Trotta F; Govoni M; Ferraccioli G
Rheumatology (Oxford); 2014 May; 53(5):875-81. PubMed ID: 24407233
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohort.
Moltó A; Paternotte S; Claudepierre P; Breban M; Dougados M
Arthritis Rheumatol; 2014 Jul; 66(7):1734-44. PubMed ID: 24623678
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
Hugle B; Burgos-Vargas R; Inman RD; O'Shea F; Laxer RM; Stimec J; Whitney-Mahoney K; Duvnjak M; Anderson M; Tse SM
Clin Exp Rheumatol; 2014; 32(3):424-31. PubMed ID: 24387974
[TBL] [Abstract][Full Text] [Related]
12. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
[TBL] [Abstract][Full Text] [Related]
13. Treatment of non-radiographic axial spondyloarthritis: it is only the beginning.
van der Horst-Bruinsma IE
Ann Rheum Dis; 2013 Jun; 72(6):789-90. PubMed ID: 23667168
[No Abstract] [Full Text] [Related]
14. The emerging use of TNF-alpha inhibitors in orbital inflammatory disease.
Kapadia MK; Rubin PA
Int Ophthalmol Clin; 2006; 46(2):165-81. PubMed ID: 16770161
[No Abstract] [Full Text] [Related]
15. Update on biologic therapy in the management of axial spondyloarthritis.
Heldmann F; Dybowski F; Saracbasi-Zender E; Fendler C; Braun J
Curr Rheumatol Rep; 2010 Oct; 12(5):325-31. PubMed ID: 20665135
[TBL] [Abstract][Full Text] [Related]
16. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
[TBL] [Abstract][Full Text] [Related]
17. [Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases].
Lapadula G
Reumatismo; 2005; 57(4 Suppl):22-9. PubMed ID: 16385352
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two.
Haibel H; Rudwaleit M; Listing J; Heldmann F; Wong RL; Kupper H; Braun J; Sieper J
Arthritis Rheum; 2008 Jul; 58(7):1981-91. PubMed ID: 18576337
[TBL] [Abstract][Full Text] [Related]
19. Infliximab treatment in psoriatic arthritis: our experience.
Rioda WT; Adorni G
Acta Biomed; 2006 Aug; 77(2):95-102. PubMed ID: 17172189
[TBL] [Abstract][Full Text] [Related]
20. Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
J Rheumatol; 2014 Jun; 41(6):1112-7. PubMed ID: 24737911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
